View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

OSE Immunotherapeutics reçoit un deuxième avis positif du Comité Indép...

OSE Immunotherapeutics reçoit un deuxième avis positif du Comité Indépendant de Surveillance des Données (IDMC) pour l’essai pivot de Phase 3 ARTEMIA évaluant Tedopi® dans le cancer du poumon non à petites cellules Nantes, le 26 février 2026 – 18h00 CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo : OSE) annonce aujourd’hui que le Comité Indépendant de Surveillance des Données (IDMC) a émis une deuxième recommandation positive concernant l’essai pivot de Phase 3 ARTEMIA en cours, évaluant Tedopi® dans le cancer du poumon non à petites cellules (CPNPC) à un stade avancé. L’IDMC a r...

 PRESS RELEASE

OSE Immunotherapeutics Receives Second Positive IDMC Recommendation fo...

OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer NANTES, France, February 26, 2026 – 6pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced that the Independent Data Monitoring Committee (IDMC) has issued a second positive recommendation for the ongoing pivotal Phase 3 ARTEMIA trial evaluating Tedopi® in advanced non-small cell lung cancer (NSCLC). The IDMC advised that the study should continue as planned, with no protocol changes. In line with the predefined study ...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aalberts: In-line FY25, but low quality / AMG: 4Q25 beat by 7%; in-line 2026 guidance / Bekaert: In-line 2025, cautious outlook for 2026 to result in c.8% consensus cut / CMB.TECH: A small bit beat but not the full story / Corbion: Dividend sweetener / CTP: Q4 results lighter due to some delays; stronger 2026 outlook / DEME: Strong FY25 numbers and FY26 outlook / Elia Group: Preview FY25 results / SBM Offshore: Another step-up in shareholder return / Syensqo: Substantial miss in 4Q25; FY26 outlo...

Guy Sips ... (+8)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Mathijs Geerts Danau
  • Wim Hoste
  • Wim Lewi

Morning Notes : ARGX BB, BEKB BB, CRBN NA, CMBT BB, SEQUA BB, SOF BB, ...

: ARGX BB, BEKB BB, CRBN NA, CMBT BB, SEQUA BB, SOF BB, UCB BB, SHUR BB, CTPNV NA, DEME BB, SYENS BB

Guy Sips
  • Guy Sips

DEME Top-line in line, EBITDA-margin 22.4% vs our 20.8% (CSS 21.0%)

DEME posted a very solid FY25 with turnover of €4.2bn, broadly in line with expectations, supported by 4% y/y growth in Offshore Energy. Dredging & Infra maintained its record FY24 level at just under €2bn, while Environmental declined 19% y/y to €272m. The order book increased to €7.6bn, benefitting from new awards and the integration of Havfram. FY25 EBITDA rose 22% y/y to a very nice €9 30.5m (KBCSe €871.6m), lifting the margin to 22.4% on strong Offshore Energy performance. Dredging & In...

 PRESS RELEASE

Full-year results 2025: record performance marks 150 years of deliver...

Full-year results 2025: record performance marks 150 years of delivery Highlights  Record results with Group turnover at 4.2 billion euros compared to 4.1 billion euros a year agoEBITDA at 931 million euros from 764 million euros a year ago, an increase of 22%, and reaching 22.4% of turnover, up from 18.6% for 2024Net profit reaching 346 million euros, compared to 288 million euros a year ago, an increase of 20%Proposed gross dividend of 4.5 euros per share, compared to 3.8 euros per share a year ago Order book stood at 7.6 billion euros at the end of the year, above both mid-year and...

 PRESS RELEASE

Jaarresultaten 2025: recordprestatie zet 150 jaar realisaties in de ve...

Jaarresultaten 2025: recordprestatie zet 150 jaar realisaties in de verf Hoogtepunten Recordresultaten De omzet van de groep bedroeg 4,2 miljard euro, tegenover 4,1 miljard euro een jaar geledenEBITDA was 931 miljoen euro tegenover 764 miljoen euro een jaar geleden, een stijging van 22% met een EBITDA-marge van 22,4%, tegenover 18,6% in 2024De nettowinst was 346 miljoen euro, tegenover 288 miljoen euro een jaar geleden, een stijging van 20%Voorstel voor een brutodividend van 4,5 euro per aandeel, tegenover 3,8 euro een jaar geleden Het orderboek bedroeg aan het einde van het jaar 7,6 milja...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ageas: Upgrading net op. result FY26 target to >€1.5bn from €1.35bn in FY25 as M&A starts contributing / CFE: Strong 2H, flips to net cash and outlook better / Deceuninck: FY25 results in line with expectations, Türkiye a tad better / GBL: Exits Umicore fully / Vopak: Five-year SBB programme announced / Wolters Kluwer: 2025 roughly in line, good 2026 outlook

Kristof Samoy ... (+4)
  • Kristof Samoy
  • Livio Luyten
  • Thomas Couvreur
  • Wim Hoste
Kristof Samoy
  • Kristof Samoy

Vopak 4Q25 in line, upgrade in cash return policy, LT OCR target upped

In line proportional EBITDA performance. Proposed cash returns (€1.8 dps) and €100m SBB exceed our expectations. Company upgrades LT OCR targets and LT cash distribution policy announcing €1.7bn returns by 2030. Proportional EBITDA26 guidance of €1150-1200m is in line with our €1187mE but a tad below €1207m CSS. Amidst all geopolitical uncertainties the report underlines the defensiveness & visibility of the business model and this amidst unfavourable FX dynamics. Buy and €50 TP reiterated.

Thijs Berkelder
  • Thijs Berkelder
 PRESS RELEASE

Vopak announces a multi-year share buyback program of up to EUR 500 mi...

Vopak announces a multi-year share buyback program of up to EUR 500 million and commences the first tranche of up to EUR 100 million Vopak announces a multi-year share buyback program of up to EUR 500 million and commences the first tranche of up to EUR 100 millionRotterdam, the Netherlands, 25th February 2026Vopak intends to commence a multi-year share buyback program of up to EUR 500 million, expected to be executed by year-end of 2030 in multiple tranches. This share buyback program is part of the shareholder distributions program of around EUR 1.7 billion through year-end 2030. In addit...

 PRESS RELEASE

Vopak reports record financial results for 2025 and announces sharehol...

Vopak reports record financial results for 2025 and announces shareholder distributions program of around EUR 1.7 billion through year-end 2030 The Netherlands, 25 February 2026  Vopak reports record financial results for 2025 and announces shareholder distributions program of around EUR 1.7 billion through year-end 2030 Key highlights  Improve Net profit -including exceptional items- FY 2025 increased by 61% to EUR 604 million and EPS of EUR 5.23 increased by 68% year-on-yearProportional operating free cash flow in FY 2025 increased to EUR 823 million leading to a record proportional o...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch